Taken together, the data suggests that the presence of two or more breast cancers with at least one case under the age of 50, and ovarian cancer at any age are significant predictors for the presence of a BRCA1 or BRCA2 mutation. This evidence concerns the gene BRCA2 and ovarian cancer.